Saro C, de la Coba C, Casado MA, Morales JM, Otero B

Infliximab is associated with decreased healthcare costs in patients with Crohn´s disease. Inflammatory Bowel Diseases

2nd Congress of the European Crohn´s and Colitis Organization (ECCO). Innsbruck, Austria. 1-3 mar 2007